BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28648947)

  • 1. Hematopoietic stem cell transplantation in the Sultanate of Oman.
    Al-Khabori M; Al-Huneini M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):305-307. PubMed ID: 28648947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation in Oman.
    Dennison D; Al Kindi S; Pathare A; Daar S; Nusrat N; Ur Rehman J; Zia F; Khan H; Khan MI; Alghazaly A; Al Zadjali S; Tauro M; Al Lawatia A; Ganguly S
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S109-S113. PubMed ID: 18724280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoselection techniques in hematopoietic stem cell transplantation.
    Li Pira G; Biagini S; Cicchetti E; Merli P; Brescia LP; Milano GM; Montanari M
    Transfus Apher Sci; 2016 Jun; 54(3):356-63. PubMed ID: 27209628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Familial Hemophagocytic Lymphohistiocytosis Who Do Not Have Matched Family Donors: Experience in Oman.
    Nazir HF; Ba Alawi FS; Al Hosni S; Al Rawas A; Dennison D
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1119-1123. PubMed ID: 32088369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic Stem Cell Transplantation for Patients with Autosomal Recessive Complete INF-λ Receptor 2 Deficiency: Experience in Oman.
    Nazir HF; Rawas AA; Tamemi SA; Zadjali SA; Hosni SA; Tauro M; Qassabi JA; Elnour I; Handgretinger R; Dennison D
    Transplant Cell Ther; 2021 Oct; 27(10):881.e1-881.e5. PubMed ID: 34293519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
    Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell-Replete Hematopoietic Cell Transplantation.
    Hosokai R; Masuko M; Shibasaki Y; Saitoh A; Furukawa T; Imai C
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):606-611. PubMed ID: 28042021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hematopoietic stem cell transplant activity in Lebanon.
    Bazarbachi A; Zahreddine A; Massoud R; El Cheikh J; Hanna C; Nasr F; Abboud M; Ibrahim A
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
    Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ
    Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.
    Gorin NC; Labopin M; Piemontese S; Arcese W; Santarone S; Huang H; Meloni G; Ferrara F; Beelen D; Sanz M; Bacigalupo A; Ciceri F; Mailhol A; Nagler A; Mohty M;
    Haematologica; 2015 Apr; 100(4):558-64. PubMed ID: 25637051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
    Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):17-30. PubMed ID: 20113884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
    Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
    Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
    Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.